Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Legacy CEO Nancy Prince joins Real Brokerage Technologies
-
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Twizzlo Announces Transparent Pricing Model for Appointment Scheduling Software
-
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Navan, Inc. Notice of April 24, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Enphase Energy, Inc. Notice of April 20, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Kyndryl Holdings, Inc. Notice of April 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
GetHookd Announces Facebook Ad Library AI Alternative With Brand Spy Feature
-
Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, File Lawsuit Against Packaging Corporation of America, Alleging Inaccurate Payment of Wages to Employees
-
Trail Life USA applauds Secretary Hegseth's recognition of its premier boy-focused program
-
ORVANA PROVIDES TAGUAS EXPLORATION UPDATE
-
Canamera Announces LIFE Offering
-
Dynamite Blockchain Announces Change in Auditor
-
/C O R R E C T I O N -- HINATURE INC./
-
The Cannabist Company Further Extends Forbearance Agreement With Senior Noteholders
-
GoldMining Announces Filing of Financial Statements, MD&A, Annual Information Form and Annual Report on Form 40-F
-
AgriBank Reports Fourth Quarter 2025 and Year-End Financial Results
-
Damon Announces Board Update
-
KIRIN HYOKETSU Expands into U.S. RTD Market with Local Production
-
Equipboard Introduces Album- and Track-Level Gear Attribution, Powering a New Era of Music Gear Discovery
-
Railtown AI Technologies Inc. Announces Closing of $3.4M Fully Subscribed Non-Brokered Private Placement
-
Empress Reports 2025 Year End Financial Results
-
U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)
-
EQV Ventures Acquisition Corp. Shareholders Approve Business Combination with Presidio
-
BTC yearly returns outperformed by first ever onchain fund memecoin!
-
Medaro Announces Closing of Private Placement
-
VTen Announces Closing of Qualifying Transaction and Private Placement
-
RETRANSMISSION: Early Warning News Release
-
Crossroads Gold Completes Acquisition of the Steiglitz Gold Project in Australia, Announces Anticipated Trading Date, and Provides Corporate and Leadership Update
-
Global Times: China-Germany open cooperation promotes mutual and global development
-
Mission Success: Rocket Lab Launches 2nd Hypersonic Test Mission in Three Months for Defense Innovation Unit
-
Electronic Caregiver Advances the Rio Grande Health Technology Corridor, Positioning Las Cruces as a National AI Healthcare Infrastructure Hub
-
Spinal Cord Injury Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals By DelveInsight | StemCyte, NervGen Pharma, VA Office of Research and Development
-
Fuchs Dystrophy Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Kowa Pharma, Trefoil Therapeutics, Design Therapeutics, Emmecell, Santen
-
Dr. B.L. Agrawal IAS Chhattisgarh: The Human Face of Bureaucracy, A Legacy of Service, Simplicity, and Spiritual Strength
-
Empathy in Medicine Initiative Launches National Student Chapter Program to Advance Communication and Compassion in Healthcare
-
Spark Energy Minerals Announces Upsizing of Private Placement to $550,000
-
Dr. Bedri Yusuf Debunks 5 Dangerous Myths About Modern Healthcare Systems
-
The End of SEO as Everyone Knows It: How FunkyMEDIA Builds Digital Empires in the Age of Answer Engine Optimization
-
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034
-
YY Group Announces US$20 Million At-The-Market Offering Facility
-
First Commerce Bancorp, Inc. Announces Conclusion of Tender Offer for its Common Stock
-
Wilton Resources Inc. Announces Grant of Stock Options
-
ION Announces Proposed Continuation to British Columbia
-
Monticello, NY Police Dept. Upgrades Computer-Aided Dispatch to Next Generation 911Systems Platform
-
Delivra Health and Its Brands LivRelief (TM) and Dream Water (TM) Report Results for Second Quarter of Fiscal 2026
-
Secretary of War Pete Hegseth Visits L3Harris Solid Rocket Motor Site
